FDA Warns of Counterfeit
Avastin in U.S.
The Food and Drug Administration (FDA) released
this warning yesterday, February 14, regarding the
distribution of counterfeit bevacizumab (Avastin) in the United
warning includes instructions for what to do if you
believe you have bought or received the counterfeit drug.
Avastin’s maker, Genentech,
released this statement about the product, including images of
both the real and counterfeit products. A Genentech spokesperson said the counterfeit product does
not look similar to authentic Avastin that is FDA-approved for the treatment of
certain cancers in the United States, including brain tumors.
Reuters reports that Roche and
Genentech are “working with the FDA and law enforcement to aid their
evaluations, determine the source of the counterfeit drug, and prevent its
further distribution.” Other sources reporting on the counterfeit drug are The Associated Press and the Wall Street Journal.
new information is made available, we will post it on our web site, www.abta.org, as well as on the ABTA Facebook page (www.facebook.com/theABTA) and via our Twitter feed (www.twitter.com/theABTA).